- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Sustainable Track Record
Global Pharmaceuticals & Biotech Sustainable Track Record
UPDATED Apr 25, 2024
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
67 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
915 | CN¥34.93 | -0.7% | -4.7% | CN¥8.3b | n/a | PE13.9x | E14.1% | 5.7% | ||
EZZ | AU$0.90 | 6.5% | 66.7% | AU$39.3m | n/a | PE11.5x | n/a | 1.1% | ||
MAB | zł16.52 | -4.0% | -9.5% | zł267.0m | zł15.83 | PE6.5x | E-103.2% | n/a | ||
AHEALTH | RM3.29 | 10.0% | 21.3% | RM2.3b | RM2.64 | PE5.9x | E-50.3% | 7.6% | ||
688278 | CN¥61.34 | -2.1% | 35.3% | CN¥24.2b | CN¥89.20 | PE41.6x | E30.5% | 0.7% | ||
HALO | US$38.46 | 1.7% | 19.3% | US$5.0b | US$50.50 | PE17.4x | E20.7% | n/a | ||
MEDP | US$389.77 | 4.1% | 97.3% | US$12.0b | US$425.47 | PE38.6x | E13.8% | n/a | ||
600976 | CN¥55.64 | -2.0% | -16.1% | CN¥8.6b | CN¥87.74 | PE16.2x | E20.7% | 2.2% | ||
MPCI | ج.م90.66 | -0.08% | 227.6% | ج.م510.0m | n/a | PE3.5x | n/a | 2.2% | ||
OCPH | ج.م100.00 | 0% | 0% | ج.م1.2b | n/a | PE8x | n/a | 0% | ||
CANB | CA$0.075 | -11.8% | -67.4% | CA$10.4m | n/a | PE3.2x | n/a | n/a | ||
RTALB | ₺12.90 | -0.8% | 61.5% | ₺1.3b | n/a | PE5.2x | n/a | n/a | ||
4728 | NT$224.00 | 0.9% | -18.8% | NT$12.2b | n/a | PE19.5x | n/a | 4.2% | ||
600436 | CN¥225.69 | -0.2% | -17.0% | CN¥132.9b | CN¥285.63 | PE45.4x | E16.3% | 1.0% | ||
1795 | NT$312.00 | 0.2% | 20.2% | NT$82.5b | NT$390.20 | PE20.1x | E20.5% | 1.1% | ||
DEVA | ₺71.90 | -2.0% | 79.6% | ₺14.4b | n/a | PE6.2x | n/a | 0.2% | ||
BETA | ₹1,306.35 | -6.6% | 67.5% | ₹12.9b | n/a | PE36.1x | n/a | n/a | ||
CURE | CA$0.015 | 0% | 50.0% | CA$1.4m | n/a | PE0.6x | n/a | n/a | ||
531569 | ₹194.65 | 9.4% | 244.1% | ₹2.2b | n/a | PE38.5x | n/a | n/a |